These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28091594)

  • 121. RBM10 regulates human TERT gene splicing and inhibits pancreatic cancer progression.
    Xiao W; Chen X; Li X; Deng K; Liu H; Ma J; Wang Z; Hu Y; Hou J
    Am J Cancer Res; 2021; 11(1):157-170. PubMed ID: 33520366
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors.
    Bielli P; Pagliarini V; Pieraccioli M; Caggiano C; Sette C
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861467
    [TBL] [Abstract][Full Text] [Related]  

  • 123. A pan-cancer analysis of synonymous mutations.
    Sharma Y; Miladi M; Dukare S; Boulay K; Caudron-Herger M; Groß M; Backofen R; Diederichs S
    Nat Commun; 2019 Jun; 10(1):2569. PubMed ID: 31189880
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Detecting and understanding meaningful cancerous mutations based on computational models of mRNA splicing.
    Lynn N; Tuller T
    NPJ Syst Biol Appl; 2024 Mar; 10(1):25. PubMed ID: 38453965
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma.
    Wu X; Zhao J; Yang L; Nie X; Wang Z; Zhang P; Li C; Hu X; Tang M; Yi Y; Du X; Xia X; Guan Y; Yu Z; Gu W; Quan X; Li L; Shi H
    J Cancer; 2022; 13(5):1565-1572. PubMed ID: 35371328
    [No Abstract]   [Full Text] [Related]  

  • 126. Molecular impact of mutations in RNA splicing factors in cancer.
    Zhang Q; Ai Y; Abdel-Wahab O
    Mol Cell; 2024 Aug; ():. PubMed ID: 39146933
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Alternative mRNA Splicing and Promising Therapies in Cancer.
    Fackenthal JD
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979496
    [TBL] [Abstract][Full Text] [Related]  

  • 128. A TARP Syndrome Phenotype Is Associated with a Novel Splicing Variant in
    Owczarek-Lipska M; Markus F; Bültmann E; Korenke GC; Neidhardt J
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421828
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing.
    Elman JS; Ni TK; Mengwasser KE; Jin D; Wronski A; Elledge SJ; Kuperwasser C
    Cell Rep; 2019 Sep; 28(13):3435-3449.e5. PubMed ID: 31553912
    [TBL] [Abstract][Full Text] [Related]  

  • 130. RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitness.
    Krishnamoorthy GP; Glover AR; Untch BR; Sigcha-Coello N; Xu B; Vukel D; Liu Y; Tiedje V; Berman K; Tamarapu PP; Acuña-Ruiz A; Saqcena M; de Stanchina E; Boucai L; Ghossein RA; Knauf JA; Abdel-Wahab O; Bradley RK; Fagin JA
    bioRxiv; 2024 Jul; ():. PubMed ID: 39026820
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Comprehensive characterization of somatic mutations associated with chimeric RNAs in human cancers.
    Wang Y; Shu M; Wang T; He T; Yuan J; Yang Y
    Int J Cancer; 2024 Aug; 155(4):683-696. PubMed ID: 38613405
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Further evidence for distinct traits associated with RBM10 missense variants.
    Poulton C; Baynam G; Pugh K; Mason M; Kiraly-Borri C; Gration D; Dreyer L; Viti L; Agostino M; Heng JI
    Clin Genet; 2022 Aug; 102(2):161-163. PubMed ID: 35645043
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Protein dynamics analysis reveals that missense mutations in cancer-related genes appear frequently on hinge-neighboring residues.
    Sayılgan JF; Haliloğlu T; Gönen M
    Proteins; 2019 Jun; 87(6):512-519. PubMed ID: 30785643
    [TBL] [Abstract][Full Text] [Related]  

  • 134. RNA splicing regulators play critical roles in neurogenesis.
    Fisher E; Feng J
    Wiley Interdiscip Rev RNA; 2022 Nov; 13(6):e1728. PubMed ID: 35388651
    [TBL] [Abstract][Full Text] [Related]  

  • 135. A comparative genomics analysis of lung adenocarcinoma for Chinese population by using panel of recurrent mutations.
    Li W; Wu M; Wang Q; Xu K; Lin F; Wang Q; Guo R
    J Biomed Res; 2020 Aug; 35(1):11-20. PubMed ID: 33342770
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Increased levels of noisy splicing in cancers, but not for oncogene-derived transcripts.
    Chen L; Tovar-Corona JM; Urrutia AO
    Hum Mol Genet; 2011 Nov; 20(22):4422-9. PubMed ID: 21862452
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Missense variant in RBM10 associated with mild and non-lethal form of TARP syndrome.
    Potter AB; O'Brien TD; Kulkarni A; McCabe S; Matthews K; Kovak K; Rogers C; Richards CS; Moore S
    Clin Genet; 2023 Aug; 104(2):269-271. PubMed ID: 36932902
    [No Abstract]   [Full Text] [Related]  

  • 138. Revealing the Determinants of Widespread Alternative Splicing Perturbation in Cancer.
    Li Y; Sahni N; Pancsa R; McGrail DJ; Xu J; Hua X; Coulombe-Huntington J; Ryan M; Tychhon B; Sudhakar D; Hu L; Tyers M; Jiang X; Lin SY; Babu MM; Yi S
    Cell Rep; 2017 Oct; 21(3):798-812. PubMed ID: 29045845
    [TBL] [Abstract][Full Text] [Related]  

  • 139. RBM10 Modulates Apoptosis and Influences TNF-α Gene Expression.
    Wang K; Bacon ML; Tessier JJ; Rintala-Maki ND; Tang V; Sutherland LC
    J Cell Death; 2012; 5():1-19. PubMed ID: 26446321
    [TBL] [Abstract][Full Text] [Related]  

  • 140. A detrimental mutation on USP40 unlocks the tumorigenesis in a rare case of lung cancer.
    Xu ZH; Wang H; Ji XY; Zhang FX; Gao BL; Hu JA; Zheng J
    Int J Clin Exp Pathol; 2019; 12(3):740-749. PubMed ID: 31933881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.